New roles opined for OPCML
- PMID: 22585855
- PMCID: PMC3854967
- DOI: 10.1158/2159-8290.CD-11-0356
New roles opined for OPCML
Abstract
OPCML, frequently inactivated in ovarian tumors, mediates its antitumor effect via binding to the extracellular domains of several important oncogenic receptor tyrosine kinases (RTK). This, in turn, leads to the downregulation of RTKs in tumor cells and results in significant inhibition of tumor growth.
©2012 AACR.
Figures
Comment on
-
The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer.Cancer Discov. 2012 Feb;2(2):156-71. doi: 10.1158/2159-8290.CD-11-0256. Cancer Discov. 2012. PMID: 22585860 Free PMC article.
References
-
- Wick M, Fan G, Loh H. Expression of OBCAM-related cDNA clones in Cos 1 cells: evidence for a phosphatidylinositol linkage to the cell membrane. Brain Res Mol Brain Res. 1996;36:322–8. - PubMed
-
- Sellar G, Watt K, Rabiasz G, Stronach E, Li L, Miller E, et al. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer. Nat Genet. 2003;34:337–43. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
